Barbara Burtness, MD, discusses the latest highlights from the AACR Annual Meeting 2026 that took place April 17-22.

Marked racial and socioeconomic disparities significantly influence survival outcomes in patients with PCNSL across the US population.

Rectal cancer is occurring earlier and killing younger adults faster, according to a study presented at Digestive Disease Week 2026, held from May 2 to 5 in Chicago. Mythili Menon Pathiyil, MD, from ...

Investigators evaluated ctDNA as a prognostic marker for patients with follicular lymphoma in the phase III GALLIUM trial.

Improvements in some domains of cognitive function seen for patients with cancer receiving chemotherapy reporting cognitive problems.

TP53 alterations independently predicted inferior remission, EFS, and OS after CAR T-cell therapy in relapsed/refractory B-ALL.

The 2026 Women’s Preventive Services Initiative’s (WPSI) updated cervical cancer issued updated screening guidelines.

There was a decline in trial initiations and unique locations during the study period, but the US remains home to nearly half of all global early-phase NSCLC clinical trials.

Researchers evaluate the impact of oncologist-delivered exercise recommendations on physical activity and quality of life in patients with lung cancer.

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more options for patients who need ...

A competing risk model provides well-calibrated absolute risk estimates for a first metachronous cutaneous squamous cell carcinoma (cSCC) after an index tumor, according to a study published online ...

Early-onset cancers have declined in men over the past 2 decades while increasing in women, according to findings published ...